News

Morgan Stanley's Equal-Weight Rating on Humana Amid Concerns

Morgan Stanley's Equal-Weight Rating on Humana Amid Concerns

Morgan Stanley Maintains Equal-Weight Rating on Humana

Morgan Stanley has recently reaffirmed an Equal-weight rating for Humana (NYSE: HUM) while setting a price target of $374.00 per share. This comes in light of concerning news regarding a decline in the number of members enrolled in 4+ Stars plans, as reported by the Centers for Medicare & Medicaid Services (CMS).

Significant Decline in 4+ Stars Enrollment

Humana announced that only about 1.6 million members, which equates to 25% of its total enrollment, will qualify for 4+ Stars plans. This marks a dramatic drop from 94% that was observed previously. The major contributor to this decline stems from the company's largest contract, identified as H5216, experiencing a decrease in rating from 4.5 Stars to 3.5 Stars.

Analyst Insights and Future Implications

The analysts at Morgan Stanley expressed concern, noting that this significant shift in enrollment was unexpected, raising questions regarding Humana's short-term outlook. They estimate that this change could impact earnings per share (EPS) for 2026 by approximately 90%, primarily due to the reduced affiliation with the higher Star-rated plans. In response, Humana has indicated its intention to evaluate potential strategies to alleviate the expected revenue challenges associated with the new 2025 Star ratings.

Review of CMS Data and Company Appeals

In reviewing CMS' preliminary data, Humana's management observed that the reduction in Star ratings might be linked to narrowly missing the higher industry benchmarks across several evaluation measures. The company has taken action, filing appeals with CMS, believing that there may be errors in the initial calculations.

Anticipated Results and Future Revenue Challenges

The complete results from CMS are set to be disclosed soon. Humana is also actively working on various strategies to address anticipated revenue impacts for 2026, acknowledging that its goal to achieve a Medicare Advantage margin of at least 3% by 2027 is now more uncertain than previously thought.

Comparative Analysis with Competitors

Furthermore, the analyst pointed out potential implications for other health companies, such as CVS Health (NYSE: CVS). It has been observed that CVS Health's key contracts seem to be performing better, which could benefit the company in a challenging market.

Current Standing of CVS Health

As indicated on the PlanFinder website, two of CVS' largest contracts are currently rated at 4.5/4 Stars and account for approximately 57% of their members, maintaining their status as 4+ Stars plans. The analysts postulate that should CVS experience a slight decrease in ratings, the anticipated impact on their 2026 EPS might be limited, around $0.13, translating to approximately 1.6%.

Understanding Humana's Market Position

Recent insights from market analysis provide a broader context for Humana’s situation. The company’s market capitalization is currently valued at about $28.87 billion with a P/E ratio of 16.36. This lower P/E ratio, alongside Humana's trading at a relatively modest revenue multiple, implies that the market may already be reflecting the worries around the recent drop in Star ratings.

Share Buybacks and Dividend History

InvestingPro notes that Humana has been actively repurchasing shares and has successfully maintained dividend payments for an impressive 14 consecutive years. These efforts are indicative of the management's confidence in the company's long-term viability, notwithstanding present challenges. Nonetheless, the stock has faced a notable downturn, with a month-to-date total return of -20.95% and a year-to-date decline of -38.48%.

Market Outlook and Profitability Predictions

Despite the setbacks, analysts are optimistic that Humana will maintain profitability within the current year. This aligns with the company’s strategies to manage the repercussions stemming from the drop in Star ratings on its revenue for 2026. For those interested in a more in-depth analysis, further insights are available, shedding light on Humana's financial standing and market dynamics.

Frequently Asked Questions

What rating did Morgan Stanley give Humana?

Morgan Stanley maintained an Equal-weight rating on Humana with a price target of $374.00.

What has caused the decline in Humana's Star ratings?

The decline is primarily due to Humana's largest contract falling from 4.5 Stars to 3.5 Stars according to the latest CMS assessment.

How does this affect Humana's earnings?

The expected impact on Humana's earnings per share for 2026 is approximately 90%, potentially leading to significant revenue challenges.

What steps is Humana taking in response to the ratings drop?

Humana is exploring various strategies to mitigate the expected revenue headwinds caused by the new Star ratings.

How does CVS Health compare in this situation?

CVS Health appears to be performing better with its key contracts, which may provide a more stable outlook compared to Humana's recent challenges.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 115

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 43

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 55

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 123

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 77

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 114

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 109

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 147

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
MassMedia's Two PRSA Wins Put Campaign Strategy in Focus

Updated Category News Views 100

A pair of trophies is nice; the underlying work matters more. MassMedia picked up two honors at the 2026 PRSA Las Vegas Valley Chapter Pinnacle Awards, presented October 28 at Siena Golf Club. One was a Pinnacle Award in Community Relations for its Safe Teen Driving work with Sam & Ash Injury Law. The other was an Award of Excellence in Reputation and Brand Management for...

Continue Reading
Legato Frames Put Tiny AI to a Real-World Hearing Test

Updated Category News Views 100

A hearing aid that never enters the ear is a deceptively brutal product challenge. It has to hear speech through a mess of restaurant clatter, traffic, wind and ordinary human commotion; it has to run all day; and, crucially, it cannot look like a medical concession somebody reluctantly straps on. Legato Frames are aiming right at that knot, with femtoAI providing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Furniture.com Launches $1,500 Giveaway for Back-to-School Fun

Updated Category News Views 154

Exciting Giveaway from Furniture.com Just in Time for School The online marketplace, Furniture.com, is inviting new social media followers to participate in an exciting giveaway allowing one lucky winner to receive a $1,500 gift card. This giveaway is perfect for anyone looking to enhance their living spaces, such as dorms, home offices, or children's rooms. Transforming...

Continue Reading
Kraken Robotics Achieves Unprecedented Growth in Q3 2025

Updated Category News Views 369

Kraken Robotics Inc. Reports Stellar Q3 2025 Results Kraken Robotics Inc. (TSXV: PNG, OTCQB: KRKNF) has recently released its financial results for Q3 2025, showcasing a remarkable growth trajectory. The company reported consolidated revenue of $31.3 million, marking a significant 60% increase from $19.6 million in the same quarter last year. This surge in revenue can be...

Continue Reading
NVIDIA Innovates AI for Robotics and Autonomous Solutions

Updated Category News Views 337

NVIDIA Enhances Robotics and Automation with New AI Models NVIDIA Corp (NASDAQ: NVDA) is making waves in the semiconductor landscape with its latest advancements in artificial intelligence (AI). With a staggering revenue exceeding $113 billion, NVIDIA has announced innovative generative AI models aimed at improving its Omniverse platform. This initiative is focused on...

Continue Reading
Takeda's ENTYVIO: Transforming IBD Treatment and Market Growth

Updated Category News Views 590

ENTYVIO's Impact on IBD Treatment Takeda Pharmaceutical continues to enhance patient care with ENTYVIO, a gut-selective biologic designed specifically for inflammatory bowel disease (IBD) management. With the recent introduction of a subcutaneous formulation, ENTYVIO has improved patient convenience, allowing for easier administration at home. This evolution in treatment...

Continue Reading
Join AM Best's Complimentary Webinar on AI Litigation Strategies

Updated Category News Views 43

AM Best Webinar Overview AM Best, a global leader in insurance credit ratings, is excited to announce a complementary webinar titled “Defending Artificial Intelligence Claims.” This informative session aims to delve into the intricate world of AI-related legal challenges. Key Discussion Points The webinar will take place at 2:00 p.m. (EST) and features a panel of...

Continue Reading